# COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2

> **NCT01639664** · NA · TERMINATED · sponsor: **Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva** · enrollment: 115 (actual)

## Conditions studied

- Shock, Septic

## Interventions

- **DEVICE:** High doses CPFA

## Key facts

- **NCT ID:** NCT01639664
- **Lead sponsor:** Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2017-10-23
- **Final completion:** 2017-10-23
- **Target enrollment:** 115 (ACTUAL)
- **Why stopped:** The interim analysis requested by the EDSMC shows higher mortality for the CPFA group compared to the controls, particularly in the first days of treatment.
- **Last updated:** 2021-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639664, "COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01639664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*